| # | Drug | Count |
|---|---|---|
| 0 | RISPERIDONE | 13 |
| 1 | OLANZAPINE | 8 |
| 2 | HALOPERIDOL | 6 |
| 3 | HALOPERIDOL LACTATE | 6 |
| 4 | QUETIAPINE | 6 |
| 5 | CLONAZEPAM | 5 |
| 6 | LEVONORGESTREL | 5 |
| 7 | MEDROXYPROGESTERONE ACETATE | 4 |
| 8 | SERTRALINE | 4 |
| 9 | ZIPRASIDONE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZIPRASIDONE | 4 | 0.0011 |
| 1 | THYROTROPIN ALFA | 1 | 0.0010 |
| 2 | HALOPERIDOL LACTATE | 6 | 0.0002 |
| 3 | RISPERIDONE | 13 | 0.0002 |
| 4 | ACETAMINOPHEN, ASPRIN, CAFFEINE | 1 | 0.0001 |
| 5 | ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE | 1 | 0.0001 |
| 6 | OLANZAPINE | 8 | 0.0001 |
| 7 | AGALSIDASE BETA | 1 | 0.0001 |
| 8 | ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE | 1 | 0.0001 |
| 9 | SUMATRIPTAN | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thyroid Stimulating Hormone [EPC] | 1 | 0.0010 |
| 1 | Typical Antipsychotic [EPC] | 6 | 0.0002 |
| 2 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 3 | Atypical Antipsychotic [EPC] | 20 | 0.0000 |
| 4 | Methylxanthine [EPC] | 1 | 0.0000 |
| 5 | Progestin [EPC] | 5 | 0.0000 |
| 6 | Central Nervous System Stimulant [EPC] | 1 | 0.0000 |
| 7 | Benzodiazepine [EPC] | 7 | 0.0000 |
| 8 | Antirheumatic Agent [EPC] | 1 | 0.0000 |
| 9 | Thiazide Diuretic [EPC] | 1 | 0.0000 |